Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data

被引：0
|
作者：
Annunziata Dattola
Maria Vittoria Cannizzaro
Mauro Mazzeo
Luca Bianchi
机构：
[1] University of Rome “Tor Vergata”,Department of Dermatology
来源：
Dermatology and Therapy | 2018年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the original publication, part Fig. 3b and c were interchanged. The correct versions are given below.
引用
收藏
页码：171 / 171
相关论文
共 50 条
  • [21] Certolizumab Pegol (Cimzia) and Ustekinumab (Stelara) for Psoriatic Arthritis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1435): : 10 - 12
  • [22] BUDGET IMPACT ANALYSIS OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS IN GREECE
    Tzanetakos, C.
    Vassilopoulos, D.
    Kourlaba, G.
    Christou, P.
    Maniadakis, N.
    VALUE IN HEALTH, 2015, 18 (07) : A638 - A639
  • [23] PGAxBSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol
    Walsh, Jessica A.
    Arledge, Terri
    Nurminen, Tommi
    Peterson, Luke
    Stark, Jeffrey
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 922 - 928
  • [24] ENTHESITIS AND CLINICAL RESPONSE IN PSORIATIC ARTHRITIS: REAL-LIFE DATA
    Ganhao, S.
    Garcia, S.
    Fernandes, B. M.
    Rato, M.
    Pinheiro, F.
    Mariz, E.
    Bernardes, M.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1157 - 1157
  • [25] Certolizumab pegol in the treatment of severe hidradenitis suppurativa after adalimumab failure: A real-life experience
    Esme, Pelin
    Akoglu, Gulsen
    Dalkiran, Cansu Dogan
    Caliskan, Ercan
    DERMATOLOGIC THERAPY, 2022, 35 (11)
  • [26] Certolizumab pegol for the treatment of psoriatic arthritis (vol 11, pg 307, 2015)
    Hansen, R. B.
    Kavanaugh, A.
    Expert Review of Clinical Immunology, 2015, 11 (05) : 689 - 689
  • [27] Certolizumab pegol for the treatment of rheumatoid arthritis
    Horton, Sarah
    Walsh, Ceara
    Emery, Paul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (02) : 235 - 249
  • [28] Hypersensitivity reaction to certolizumab pegol in a patient affected by psoriatic arthritis
    Napolitano, Maddalena
    Gallo, Lucia
    Megna, Matteo
    Fabbrocini, Gabriella
    Nocerino, Mariateresa
    Abategiovanni, Luisa
    Patruno, Cataldo
    DERMATOLOGIC THERAPY, 2019, 32 (03)
  • [29] The Effect of Certolizumab Pegol on Skin Manifestations of Psoriatic Arthritis over 4 Years of Treatment
    Khraishi, Majed
    Gottlieb, Alice B.
    Hoepken, Bengt
    Peterson, Luke
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [30] COST-UTILITY ANALYSIS OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS IN GREECE
    Tzanetakos, C.
    Vassilopoulos, D.
    Kourlaba, G.
    Christou, P.
    Maniadakis, N.
    VALUE IN HEALTH, 2015, 18 (07) : A646 - A647
12345